X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1534) 1534
Newspaper Article (1391) 1391
Newsletter (251) 251
Publication (214) 214
Magazine Article (92) 92
Web Resource (57) 57
Trade Publication Article (50) 50
Book Review (42) 42
Report (34) 34
Book Chapter (25) 25
Transcript (11) 11
Conference Proceeding (9) 9
Reference (8) 8
Book / eBook (5) 5
Government Document (4) 4
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ebola virus (2646) 2646
vaccines (1638) 1638
index medicus (877) 877
viruses (816) 816
humans (795) 795
epidemics (754) 754
animals (628) 628
ebola virus infections (597) 597
medical research (557) 557
public health (500) 500
infectious diseases (498) 498
research (491) 491
virology (379) 379
health aspects (371) 371
virus diseases (356) 356
infections (345) 345
microbiology (320) 320
clinical trials (311) 311
immunology (305) 305
studies (296) 296
hemorrhagic fever, ebola - prevention & control (266) 266
multidisciplinary sciences (264) 264
pharmaceutical industry (252) 252
immunization (247) 247
proteins (246) 246
infection (243) 243
ebolavirus - immunology (242) 242
disease (237) 237
medicine (228) 228
ebolavirus - genetics (223) 223
ebola (222) 222
medicine, experimental (204) 204
research article (204) 204
hemorrhagic-fever (197) 197
genomes (196) 196
hemorrhagic fever, ebola - virology (195) 195
mice (194) 194
hemorrhagic fever, ebola - epidemiology (191) 191
fever (188) 188
vaccination (188) 188
female (187) 187
laboratories (187) 187
viral diseases (186) 186
disease control (181) 181
nonhuman-primates (179) 179
science (172) 172
article (170) 170
prevention (167) 167
epidemiology (166) 166
hemorrhagic fever, ebola - immunology (166) 166
ebola-virus (165) 165
analysis (163) 163
mortality (154) 154
glycoproteins (147) 147
researchers (146) 146
outbreaks (145) 145
biology (144) 144
influenza (137) 137
male (135) 135
antibodies (134) 134
glycoprotein (134) 134
pathogens (134) 134
genetic aspects (131) 131
hemorrhagic fever (130) 130
vaccine (129) 129
ebola vaccines - immunology (125) 125
research & development--r&d (125) 125
disease outbreaks (123) 123
care and treatment (122) 122
marburg virus disease (122) 122
primates (122) 122
genetic vectors (121) 121
zika virus (115) 115
immune response (113) 113
mutation (111) 111
marburg virus (110) 110
medicine and health sciences (110) 110
pathogenesis (110) 110
biology and life sciences (105) 105
antigens (104) 104
immunoglobulins (104) 104
immune system (102) 102
product development (100) 100
tropical diseases (98) 98
medicine, research & experimental (97) 97
parasitology (97) 97
viral vaccines - immunology (97) 97
disease transmission (96) 96
disease models, animal (95) 95
filovirus (95) 95
cell line (94) 94
usage (94) 94
ebolavirus (91) 91
fatalities (91) 91
genomics (91) 91
transmission (91) 91
rna viruses (90) 90
antibodies, viral - blood (89) 89
ebolavirus - pathogenicity (89) 89
ebolavirus - physiology (88) 88
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3423) 3423
French (13) 13
Japanese (2) 2
Polish (2) 2
Portuguese (2) 2
Spanish (2) 2
Chinese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature medicine, ISSN 1078-8956, 10/2014, Volume 20, Issue 10, pp. 1126 - 1129
Journal Article
Journal Article
Journal of Virology, ISSN 0022-538X, 10/2011, Volume 85, Issue 20, pp. 10605 - 10616
Journal Article
Vaccine, ISSN 0264-410X, 2010, Volume 29, Issue 2, pp. 304 - 313
Abstract Ebola virus causes irregular outbreaks of severe hemorrhagic fever in equatorial Africa. Case mortality remains high; there is no effective treatment... 
Allergy and Immunology | Filovirus vaccine | Gene-based vaccines | Adenovirus | Ebola | NONHUMAN-PRIMATES | MEDICINE, RESEARCH & EXPERIMENTAL | OF-CONCEPT | RHESUS-MONKEYS | PHASE-1 SAFETY | IMMUNOLOGY | ADENOVIRUS VECTORS | HEMORRHAGIC-FEVER | TYPE-1 GAG GENE | CANDIDATE VACCINE | INDUCED IMMUNITY | HIV-1 VACCINE | Ebola Vaccines - genetics | Hemorrhagic Fever, Ebola - prevention & control | Humans | Middle Aged | Male | Neutralization Tests | Ebolavirus - genetics | Antibodies, Viral - blood | Ebolavirus - immunology | Young Adult | Adult | Ebola Vaccines - immunology | Female | Hemorrhagic Fever, Ebola - immunology | Placebos - administration & dosage | Cytokines - immunology | Viral Envelope Proteins - genetics | Double-Blind Method | Enzyme-Linked Immunosorbent Assay | Ebola Vaccines - adverse effects | Vaccines, Attenuated - immunology | Animals | Adolescent | T-Lymphocytes - immunology | Viral Envelope Proteins - immunology | Adenoviruses, Human - genetics | Genetic Vectors | Vaccines, Attenuated - adverse effects | Antibodies, Neutralizing - blood | Vaccines, Attenuated - genetics | Ebola virus | Proteins | Clinical trials | Fatalities | Infections | Vaccines | Deoxyribonucleic acid--DNA | Hemorrhagic fever | Cytokines | Mortality | Antibodies | DNA vaccines | Glycoproteins | Lymphocytes T | Immunity | Immune response (humoral) | Envelopes | Immunogenicity | Serotypes | Replication | Enzyme-linked immunosorbent assay
Journal Article
Journal Article
Journal of Virology, ISSN 0022-538X, 05/2017, Volume 91, Issue 10
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 03/2012, Volume 6, Issue 3, p. e1567
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 8, pp. 854 - 866
Summary Background The 2014 Zaire Ebola virus outbreak highlighted the need for a safe, effective vaccine with a rapid onset of protection. We report the... 
Infectious Disease | Ebola Vaccines - genetics | Hemorrhagic Fever, Ebola - prevention & control | Immunoglobulin G - blood | United States | Humans | Middle Aged | Male | Neutralization Tests | Vaccines, Synthetic - immunology | Ebolavirus - genetics | Healthy Volunteers | Antibodies, Viral - blood | Ebolavirus - immunology | Drug Carriers | Drug-Related Side Effects and Adverse Reactions - pathology | Incidence | Young Adult | Vaccines, Synthetic - adverse effects | Vesiculovirus - genetics | Adult | Ebola Vaccines - immunology | Female | Placebos - administration & dosage | Viral Envelope Proteins - genetics | Double-Blind Method | Enzyme-Linked Immunosorbent Assay | Vaccines, Synthetic - genetics | Viral Plaque Assay | Ebola Vaccines - administration & dosage | Injections, Intramuscular | Ebola Vaccines - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Adolescent | Viral Envelope Proteins - immunology | Vaccines, Synthetic - administration & dosage | Genetic Vectors | Antibodies, Neutralizing - blood | Ebola virus | Adults | Vaccines | Health care | Headache | Epidemics | Laboratories | Funding | Viremia | Immunoglobulin G | Vaccination | Viral diseases | Antibodies | Clinical trials | Viruses | Outbreaks | Arthritis | Shivering | Dermatitis | Chills | Consortia | Pain | Immunology | Motivation | Lists | Safety | Drug dosages | Enzyme-linked immunosorbent assay | Recombinant | Swelling | Research & development--R&D | Glycoprotein | Fatigue | Glycoproteins | Injection | Myalgia | Seroconversion | Monkeys & apes | Fever | Stomatitis | Immunogenicity | West Nile virus | Federal agencies | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 51, pp. 7344 - 7351
Abstract Recombinant adenoviral vector (rAd)-based vaccines are currently being developed for several infectious diseases and cancer therapy, but pre-existing... 
Allergy and Immunology | Adenoviral vectors | Vaccine development | Humoral immune response | Simian adenovirus | Chimpanzee adenovirus | Cellular immune response | NONHUMAN-PRIMATES | MEDICINE, RESEARCH & EXPERIMENTAL | V3 LOOP | NEUTRALIZING ANTIBODIES | DENDRITIC CELLS | RHESUS-MONKEYS | ENVELOPE GLYCOPROTEIN | IMMUNOLOGY | IMMUNIZATION | T-CELL RESPONSES | IMMUNE-RESPONSES | GENE-TRANSFER | Vaccines, DNA - genetics | Adenoviruses, Simian - immunology | AIDS Vaccines - isolation & purification | Immunoglobulin G - blood | Viral Vaccines - genetics | AIDS Vaccines - immunology | Vaccines, DNA - immunology | Drug Discovery - methods | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Drug Carriers | Vaccines, Synthetic - isolation & purification | Adenoviruses, Simian - genetics | CD4-Positive T-Lymphocytes - immunology | Viral Vaccines - isolation & purification | Female | Vaccines, DNA - isolation & purification | SAIDS Vaccines - isolation & purification | Vaccines, Synthetic - genetics | SAIDS Vaccines - genetics | Animals | SAIDS Vaccines - immunology | AIDS Vaccines - genetics | Mice, Inbred BALB C | CD8-Positive T-Lymphocytes - immunology | Genetic Vectors | Viral Vaccines - immunology | Monkeys | Vaccines | T cells | Health aspects | Immunotherapy | Immunoglobulin G | Antigens | Medical research | AIDS vaccines | Immune response | Communicable diseases | Adenoviruses | Medicine, Experimental | Development and progression | Studies | Ebola virus | Patents | Immunoglobulins | Inventors | Clinical trials | Viruses | Monkeys & apes | Vectors (Biology) | Deoxyribonucleic acid--DNA
Journal Article
Journal Article